Sopharma’s Board of Directors filed a GSM invitation for 25 October 2024, where shareholders will vote on distributing BGN 0.075 gross DPS from the H1’24 financial result. The total amount to be distributed should be c. BGN 12.4m (165.7m outstanding shares). The payout ratio stands at 55.8% while the annual dividend yield when accounting for the BGN 0.09 dividend voted in June comes to 2.8%. The shareholders would also vote on new buyback procedure under the following conditions: not more than 3% of the capital per calendar year at a minimum price per share of BGN 1 and a maximum price per share of BGN 7.00 with 18 months term of the procedure. Note that the current buyback procedure has an upper price limit of BGN 6.50 while Sopharma has treasury stock of 7.46% of the capital.